Third Harmonic Bio
multiple upcoming clinical catalysts | Third Harmonic Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2022
Slide
18 of 24
Similar slides by Third Harmonic Bio
See diffirences between slides (animation)
Investor Presentation
October 2022
multiple upcoming clinical catalysts | Third Harmonic Bio
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
October 2024
upcoming catalysts | NeuroSense Therapeutics
Kiromic BioPharma
Investor Presentation
May 2023
upcoming milestones authorization to evaluate in non small cell lung cancer may beginning of first in human trial activation for data results from first patient in clinical trial by end of initiation of clinical trials expansion cohort submission of new for and | Kiromic BioPharma
Aeglea BioTherapeutics
Investor Presentation
September 2023
spy is a potentially best in class anti a with near term risking studies anticipated | Aeglea BioTherapeutics
Codiak
IPO
October 2020
multiple catalysts for near term value creation | Codiak
Other recent decks by Third Harmonic Bio
See all presentations (2 decks)
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights